Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: Chronology of clonal emergence and changes in mutant allele burden over time

British Journal of Haematology

Volumn 135, Issue 5, 2006, Pages 683-687

  Lasho, Terra L ^a   Pardanani, Animesh ^a   McClure, Rebecca F ^a   Mesa, Ruben A ^a   Levine, Ross L ^b,c   Gary Gilliland, D ^b,c,d   Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Essential thrombocythaemia; MPLW515K; MPLW515L; Myelofibrosis

Indexed keywords

ALLELE; ARTICLE; BONE MARROW; CHRONOLOGY; CLONAL VARIATION; CORRELATION ANALYSIS; GENE MUTATION; HUMAN; MOLECULAR CLONING; MUTANT; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PHENOTYPIC VARIATION; PRIORITY JOURNAL; THROMBOCYTHEMIA;

ALLELES; BONE MARROW CELLS; CHROMATOGRAPHY; CLONE CELLS; DNA; GENE FREQUENCY; GRANULOCYTES; HUMANS; JANUS KINASE 2; MUTATION; MYELOFIBROSIS; MYELOID METAPLASIA; RECEPTORS, THROMBOPOIETIN; THROMBOCYTOSIS; TIME;

EID: 33750550297     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06348.x     Document Type: Article

References (11)

1. James, C., Ugo, V., Le Couedic, J.P., Staerk, J., Delhommeau, F., Lacout, C., Garcon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., Villeval, J.L., Constantinescu, S.N., Casadevall, N. & Vainchenker, W. (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434, 1144-1148.
2. + cell fractions in myeloproliferative disorders with homozygous JAK2V617F in granulocytes. British Journal of Haematology, 130, 797-799.
3. Levine, R.L., Belisle, C., Wadleigh, M., Zahrieh, D., Lee, S., Chagnon, P., Gilliland, D.G. & Busque, L. (2006) X-inactivation based clonality analysis and quantitative JAK2V617F assessment reveals a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F negative ET and MMM patients with clonal hematopoiesis. Blood, 107, 4139-4141.
4. Lippert, E., Boissinot, M., Kralovics, R., Girodon, F., Dobo, I., Praloran, V., Boiret-Dupre, N., Skoda, R.C. & Hermouet, S. (2006) The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera. Blood, 108, 1865-1867.
5. McClure, R., Mai, M. & Lasho, T. (2006) Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders. Leukemia, 20, 168-171.
6. Pardanani, A.D., Levine, R.L., Lasho, T., Pikman, Y., Mesa, R.A., Wadleigh, M., Steensma, D.P., Elliott, M.A., Wolanskyj, A.P., Hogan, W.J., McClure, R.F., Litzow, M.R., Gilliland, D.G. & Tefferi, A. (2006) MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood, prepublished online July 25, 2006; DOI 10.1182/blood-2006-04- 018879.
7. Pikman, Y., Lee, B.H., Mercher, T., McDowell, E., Ebert, B.L., Gozo, M., Cuker, A., Wernig, G., Moore, S., Galinsky, I., Deangelo, D.J., Clark, J.J., Lee, S.J., Golub, T.R., Wadleigh, M., Gilliland, D.G. & Levine, R.L. (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Medicine, 3, e270.
8. Scott, L.M., Scott, M.A., Campbell, P.J. & Green, A.R. (2006) Progenitors homozygous for the V617F JAK2 mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood, 108, 2435-2437.
9. Tefferi, A., Lasho, T.L. & Gilliland, G. (2005) JAK2 mutations in myeloproliferative disorders. The New England Journal of Medicine, 353, 1416-1417.
10. Vardiman, J.W., Brunning, R.D. & Harris, N.L. (2001) WHO histological classification of chronic myeloproliferative diseases. In: Tumours of the Haematopoietic and Lymphoid Tissues (ed. by E.S. Jaffe, N.L. Harris, H. Stein & J.W. Vardiman ), pp. 17-44. International Agency for Research on Cancer (IARC) Press, Lyon.
11. Wernig, G., Mercher, T., Okabe, R., Levine, R.L., Lee, B.H. & Gilliland, D.G. (2006) Expression of JAK2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood, 107, 4274-4281.